Telomerase Activating Compounds for Niche Fertility Applications
Legal Citation
Summary of the Inventive Concept
The present inventive concept discloses specialized telomerase activating compounds and systems for promoting fertility in unique operational environments, such as high-altitude settings, radiation exposure, disaster relief scenarios, and compromised immune systems.
Background and Problem Solved
The original patent disclosed telomerase activating compounds for general fertility applications. However, these compounds may not be effective or suitable for specific, high-stress environments. The present inventive concept addresses this limitation by adapting the compounds and systems for these niche applications, providing a targeted solution for individuals in need.
Detailed Description of the Inventive Concept
The inventive concept comprises telomerase activating compounds and systems tailored for specific, high-stress environments. For instance, Claim 1 discloses a system for promoting fertility in high-altitude environments, comprising a telomerase-activating compound and a delivery mechanism adapted for use at elevated atmospheric pressures. Claim 2 describes a method for enhancing fertility in a subject exposed to radiation, involving the administration of a telomerase-activating compound in conjunction with a radioprotective agent. Similarly, Claims 3-5 detail fertility treatment kits, systems, and methods for disaster relief scenarios, chemotherapy, and compromised immune systems, respectively. These specialized solutions ensure optimal fertility promotion in these unique operational environments.
Novelty and Inventive Step
The present inventive concept introduces novel, non-obvious variations of telomerase activating compounds and systems, specifically designed for niche fertility applications. The inventive step lies in the adaptation of the original compounds and systems to address the unique challenges and requirements of these high-stress environments.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include customized telomerase activating compounds and systems for other specialized environments, such as extreme temperatures, high-stress occupations, or specific genetic conditions. These variations would further expand the scope of the inventive concept, ensuring broad conceptual coverage.
Potential Commercial Applications and Market
The present inventive concept has significant commercial potential in the fertility and reproductive health industries, particularly in niche markets catering to individuals in high-stress environments. Target industries may include disaster relief organizations, high-altitude research stations, and specialized fertility clinics. The inventive concept's unique value proposition lies in its ability to provide targeted, effective fertility solutions for these underserved markets.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K31/09 |
| A | A61 | A61K31/137 |
| A | A61 | A61K31/4025 |
| A | A61 | A61K31/4545 |
| A | A61 | A61K31/5377 |
| A | A61 | A61K31/66 |
| A | A61 | A61P15/08 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Reproductive medicine, pharmaceutical compositions, and telomerase activation technologies with a focus on fertility enhancement and cellular interventions
Person of Ordinary Skill (PHOSITA) Profile
A skilled practitioner with advanced degrees in molecular biology, pharmacology, or reproductive medicine, possessing expertise in compound design, cellular signaling, and therapeutic interventions for fertility-related applications
Obviousness Rationale
A person having ordinary skill in the art would recognize that the PTD's variations represent predictable extensions of the source patent's core telomerase activation technology by applying known methodological adaptations to specific environmental and physiological contexts. The disclosed variations demonstrate systematic modifications that a skilled practitioner would naturally explore when considering fertility preservation across diverse challenging scenarios. These adaptations represent logical combinations of known techniques with the foundational telomerase activation compounds disclosed in the source patent.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,516 |
|---|---|
| Title | Telomerase activating compounds for use in fertility and related applications |
| Assignee(s) | Neuromagen Pharma, Ltd. |